Mesenchymal Cell News Volume 4.32 | Aug 13 2012

    0
    22

    Mesenchymal Cell News 4.32 August 13, 2012

         In this issue: Publications Industry News | Policy News | Events | Jobs 
    Cell Therapy News on Facebook  Mesenchymal Cell News on Twitter

    TOP STORY
    Cystamine-Terminated Poly(Beta-Amino Ester)s for siRNA Delivery to Human Mesenchymal Stem Cells and Enhancement of Osteogenic Differentiation
    Enhancing human mesenchymal stem cell (hMSC) differentiation via RNA interference could provide an effective way of controlling cell fate for tissue engineering, but a safe and effective delivery vehicle must first be developed. Researchers evaluated an array of synthetic end-modified poly(beta-amino ester)-based nanoparticles to optimize siRNA delivery into hMSCs. [Biomaterials] Abstract

    [Free Webinar] A Guide To Successful Flow Cytometry Analysis of ALDHbr Cells - Watch Now.

    PUBLICATIONS (Ranked by impact factor of the journal)

    Effects of Intracoronary Delivery of Allogenic Bone Marrow-Derived Stem Cells Expressing Heme Oxygenase-1 on Myocardial Reperfusion Injury
    Scientists investigated the effects of intracoronary infusion of allogenic bone marrow cells overexpressing heme oxygenase-1 in the porcine model of myocardial infarction. [Thromb Haemost] Abstract

    Hypoxia-Inducible Factor 1a Contributes to Cardiac Healing in Mesenchymal Stem Cells Mediated Cardiac Repair
    Researchers provided evidence for a crucial role of hypoxia-inducible factor 1a (HIF-1a) on mesenchymal stem cell biology and suggested the stabilization of HIF-1a as a novel strategy for cellular therapies. [Stem Cells Dev] Abstract

    H3K9me-Enhanced DNA Hypermethylation of p16INK4a Gene: An Epigenetic Signature for Spontaneous Transformation of Rat Mesenchymal Stem Cells
    To explore the mechanisms underlying spontaneous transformation of mesenchymal stem cells (MSC), changes in senescence-associated molecules, particularly the epigenetic modification of p16INK4a gene including histone H3 lysines 27/9 methylation (H3K27/9me) and DNA methylation, were investigated in cultured adult rat bone marrow MSCs at different stages during the transformation process. [Stem Cells Dev] Abstract

    β-Cell Regeneration Mediated by Human Bone Marrow Mesenchymal Stem Cells
    Investigators tested the ability of human bone marrow mesenchymal stem cells genetically modified to transiently express vascular endothelial growth factor or pancreatic-duodenal homeobox 1 to reverse diabetes and whether these cells were differentiated into β-cells or mediated recovery through alternative mechanisms. [PLoS One] Full Article

    Adenoviral Transduction of Mesenchymal Stem Cells: In Vitro Responses and In Vivo Immune Responses after Cell Transplantation
    Researchers investigated whether adenovirus (Ad)-modification of mesenchymal stem cells (MSCs) alters their immunological properties in vitro and in vivo. They found that Ad-transduction of MSCs does not lead to up-regulation of major histocompatibility complex class I and II and co-stimulatory molecules CD80 and CD86. [PLoS One] Full Article

    The Effects of Cyclic Hydrostatic Pressure on Viability and Chondrogenesis of Human Adipose and Bone Marrow Derived Mesenchymal Stem Cells in Three-Dimensional Agarose Constructs
    Scientists investigated the effects of cyclic hydrostatic pressure on chondrogenic differentiation of human adipose-derived stem cells seeded in three-dimensional agarose constructs in complete growth medium in the absence of chondrogenic inductive factors. [Tissue Eng Part A] Abstract

    Human Adipose Derived Stem Cells Enhance the Angiogenic Potential of Endothelial Progenitor Cells But Not of Human Umbilical Vein Endothelial Cells
    Data suggests that cellular communications between adipose derived stem cells and endothelial progenitor cells (EPCs) is triggered by cell-cell contact or at least close proximity, which is partially mediated by secreted VEGF leading to the enhancement of angiogenic properties in EPCs but not in human umbilical vein endothelial cells. [Tissue Eng Part A] Abstract

    Human Adipose Tissue-Derived Multilineage Progenitor Cells Exposed to Oxidative Stress Induce Neurite Outgrowth in PC12 Cells through p38 MAPK Signaling
    Researchers examined the role of oxidative stress on human adipose-derived multilineage progenitor cells in neurite outgrowth in cells of the rat pheochromocytoma cell line (PC12). [BMC Cell Biol] Abstract | Full Article

    A Novel Strategy to Enhance Mesenchymal Stem Cell Migration Capacity and Promote Tissue Repair in an Injury Specific Fashion
    Investigators demonstrated that promoting migration of mesenchymal stem cells could increase their therapeutic potential and indicates a new therapeutic paradigm for organ repair. [Cell Transplant] Abstract

    50,000 scientists receive our newsletters. Do your colleagues? Click to share this newsletter now.

    INDUSTRY NEWS

    NIH Announces Winners of Undergraduate Biomedical Engineering Competition
    The National Institute of Biomedical Imaging and Bioengineering announced the winners in the three categories of the DEBUT challenge, a biomedical engineering design competition for teams of undergraduate students. [National Institutes of Health (NIH), United States] Press Release

    Wellcome Trust and MRC Invest in World-Class Stem Cell Institute at Cambridge
    Two of the UK’s largest funders of medical research are to invest £8 million in a new world-leading centre for stem cell biology and medicine at the University of Cambridge. The Wellcome Trust-Medical Research Council (MRC) Cambridge Stem Cell Institute will advance our understanding of stem cells and their potential to treat a range of life-threatening conditions that currently have no effective cures. [University of Cambridge]
    Press Release

    Stem Cell Society Singapore Symposium 2012 - Stem Cell Based Therapy

    POLICY NEWS

    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)

    EVENTS

    NEW World Stem Cells Regenerative Medicine Congress
    May 21-23, 2013
    London, United Kingdom

    Visit
    our events page to see a complete list of events in the mesenchymal cell community.

    JOB OPPORTUNITIES

    Quality Control Operations Coordinator (STEMCELL Technologies, Inc.)

    Research Technologist – Media Development (STEMCELL Technologies, Inc.)

    Research Technologist – Research and Development (STEMCELL Technologies, Inc.)

    Scientific Communications & Publishing Coordinator (STEMCELL Technologies, Inc.)

    Scientist – Mesenchymal Cell Research (STEMCELL Technologies, Inc.)

    Postdoctoral Position – Molecular Cell Biology (Weizmann Institute of Science)

    Postdoctoral Position – Cancer Biology (Georgia Health Science University)

    Postdoctoral Position – Mesenchymal Progenitors, Lung Development and Repair (Boston University)


    Postdoctoral Position – Lung Stem Cell Research (University of Bern)

    Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

    Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit!

    Comments or Suggestions? Email info@connexoncreative.com with your feedback.

    Learn more about Mesenchymal Cell News: Archives | Events | Contact Us